Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
6,867
Total Claims
$595K
Drug Cost
436
Beneficiaries
$1,365
Cost/Patient
Risk Score Breakdown 64/100
Score components are additive. Read full methodology
Peer Comparison vs. 218,535 Nurse Practitioner providers
+1754%
Opioid rate vs peers
70.1% vs 3.8% avg
+16%
Cost per patient vs peers
$1,365 vs $1,174 avg
+9%
Brand preference vs peers
9.7% vs 8.9% avg
⚠️ This provider has metrics more than 3 standard deviations above their specialty average in one or more categories.
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
🔎 Data Overview
Opioid prescribing rate is 1,754% above the average for Nurse Practitioner providers. While some providers legitimately treat pain-heavy populations, deviations of this magnitude are rare and warrant examination.
This provider co-prescribes opioids and benzodiazepines — a combination carrying an FDA Black Box Warning due to increased risk of respiratory depression and death. While sometimes clinically necessary, this combination requires careful justification.
Composite risk score of 64/100 places this provider in the "High Risk" category — the top 0.017% of all Medicare Part D prescribers. Multiple independent risk factors are contributing simultaneously.
Insights generated from CMS data analysis. Statistical patterns are not accusations — always consider clinical context.
Opioid Prescribing
70.1%
Opioid Rate
4,816
Opioid Claims
$455K
Opioid Cost
38.0%
Long-Acting Rate
This provider's opioid prescribing rate of 70.1% is above the 20% threshold that CMS considers elevated.
Brand vs Generic
Brand: 665 claims · $383K
Generic: 6,202 claims · $212K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Oxycodone Hcl | 187 | $141K |
| Oxycodone Myristate | 232 | $132K |
| Methylnaltrexone Bromide | 21 | $50K |
| Fentanyl | 302 | $36K |
| Oxycodone Hcl/Acetaminophen | 948 | $34K |
| Oxycodone Hcl | 1,239 | $26K |
| Morphine Sulfate | 784 | $23K |
| Oxymorphone Hcl | 33 | $22K |
| Pregabalin | 19 | $14K |
| Tapentadol Hcl | 11 | $13K |
| Linaclotide | 18 | $10K |
| Gabapentin | 537 | $9,782 |
| Hydrocodone/Acetaminophen | 373 | $9,714 |
| Naloxone Hcl | 105 | $8,782 |
| Methadone Hcl | 269 | $6,727 |
Prescribing Profile
39
Unique Drugs
64.0
Anomaly Score
Patient Profile
65
Avg Age
62%
Female
1.32
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data